Electrocardiographic abnormalities in COVID-19 patients visiting the emergency department: a multicenter retrospective study.


Journal

BMC emergency medicine
ISSN: 1471-227X
Titre abrégé: BMC Emerg Med
Pays: England
ID NLM: 100968543

Informations de publication

Date de publication:
19 11 2021
Historique:
received: 02 02 2021
accepted: 03 11 2021
entrez: 20 11 2021
pubmed: 21 11 2021
medline: 25 11 2021
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be associated with myocardial injury. Identification of at-risk patients and mechanisms underlying cardiac involvement in COVID-19 remains unclear. During hospitalization for COVID-19, high troponin level has been found to be an independent variable associated with in-hospital mortality and a greater risk of complications. Electrocardiographic (ECG) abnormalities could be a useful tool to identify patients at risk of poor prognostic. The aim of our study was to assess if specific ECGs patterns could be related with in-hospital mortality in COVID-19 patients presenting to the ED in a European country. From February 1st to May 31st, 2020, we conducted a multicenter study in three hospitals in France. We included adult patients (≥ 18 years old) who visited the ED during the study period, with ECG performed at ED admission and diagnosed with COVID-19. Demographic, comorbidities, drug exposures, signs and symptoms presented, and outcome data were extracted from electronic medical records using a standardized data collection form. The relationship between ECG abnormalities and in-hospital mortality was assessed using univariate and multivariable logistic regression analyses. An ECG was performed on 275 patients who presented to the ED. Most of the ECGs were in normal sinus rhythm (87%), and 26 (10%) patients had atrial fibrillation/flutter on ECG at ED admission. Repolarization abnormalities represented the most common findings reported in the population (40%), with negative T waves representing 21% of all abnormalities. We found that abnormal axis (adjusted odds ratio: 3.9 [95% CI, 1.1-11.5], p = 0.02), and left bundle branch block (adjusted odds ratio: 7.1 [95% CI, 1.9-25.1], p = 0.002) were significantly associated with in-hospital mortality. ECG performed at ED admission may be useful to predict death in COVID-19 patients. Our data suggest that the presence of abnormal axis and left bundle branch block on ECG indicated a higher risk of in-hospital mortality in COVID-19 patients who presented to the ED. We also confirmed that ST segment elevation was rare in COVID-19 patients.

Sections du résumé

BACKGROUND
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be associated with myocardial injury. Identification of at-risk patients and mechanisms underlying cardiac involvement in COVID-19 remains unclear. During hospitalization for COVID-19, high troponin level has been found to be an independent variable associated with in-hospital mortality and a greater risk of complications. Electrocardiographic (ECG) abnormalities could be a useful tool to identify patients at risk of poor prognostic. The aim of our study was to assess if specific ECGs patterns could be related with in-hospital mortality in COVID-19 patients presenting to the ED in a European country.
METHODS
From February 1st to May 31st, 2020, we conducted a multicenter study in three hospitals in France. We included adult patients (≥ 18 years old) who visited the ED during the study period, with ECG performed at ED admission and diagnosed with COVID-19. Demographic, comorbidities, drug exposures, signs and symptoms presented, and outcome data were extracted from electronic medical records using a standardized data collection form. The relationship between ECG abnormalities and in-hospital mortality was assessed using univariate and multivariable logistic regression analyses.
RESULTS
An ECG was performed on 275 patients who presented to the ED. Most of the ECGs were in normal sinus rhythm (87%), and 26 (10%) patients had atrial fibrillation/flutter on ECG at ED admission. Repolarization abnormalities represented the most common findings reported in the population (40%), with negative T waves representing 21% of all abnormalities. We found that abnormal axis (adjusted odds ratio: 3.9 [95% CI, 1.1-11.5], p = 0.02), and left bundle branch block (adjusted odds ratio: 7.1 [95% CI, 1.9-25.1], p = 0.002) were significantly associated with in-hospital mortality.
CONCLUSIONS
ECG performed at ED admission may be useful to predict death in COVID-19 patients. Our data suggest that the presence of abnormal axis and left bundle branch block on ECG indicated a higher risk of in-hospital mortality in COVID-19 patients who presented to the ED. We also confirmed that ST segment elevation was rare in COVID-19 patients.

Identifiants

pubmed: 34798827
doi: 10.1186/s12873-021-00539-8
pii: 10.1186/s12873-021-00539-8
pmc: PMC8603337
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

141

Informations de copyright

© 2021. The Author(s).

Références

BMC Emerg Med. 2020 Dec 11;20(1):97
pubmed: 33308165
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
Intern Emerg Med. 2021 Mar;16(2):419-427
pubmed: 32984929
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Intern Emerg Med. 2021 Oct;16(7):1945-1950
pubmed: 33484453
Eur Heart J. 2020 May 14;41(19):1859
pubmed: 32282027
Intern Emerg Med. 2020 Nov;15(8):1415-1424
pubmed: 32772283
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
JAMA. 2015 Jan 20;313(3):264-74
pubmed: 25602997
JACC Case Rep. 2020 Jul 15;2(9):1284-1288
pubmed: 32342049
Intern Emerg Med. 2020 Aug;15(5):835-839
pubmed: 32405816
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Europace. 2020 Dec 23;22(12):1848-1854
pubmed: 32944767
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Intern Emerg Med. 2020 Aug;15(5):755-758
pubmed: 32399954
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Ann Noninvasive Electrocardiol. 2021 Jan;26(1):e12799
pubmed: 32975832
Clin Infect Dis. 2017 Nov 13;65(11):1806-1812
pubmed: 29020164
J Card Fail. 2020 Jul;26(7):626-632
pubmed: 32544622
Clin Infect Dis. 2007 Jul 15;45(2):158-65
pubmed: 17578773
Respir Res. 2016 Aug 04;17(1):98
pubmed: 27491412
Am J Cardiol. 2012 Dec 15;110(12):1836-40
pubmed: 23000104
Lancet. 2020 May 9;395(10235):1516
pubmed: 32334650
Am J Respir Crit Care Med. 2017 Sep 1;196(5):609-620
pubmed: 28614669
Am J Emerg Med. 2021 Jun;44:352-357
pubmed: 32331955
JAMA Cardiol. 2020 Nov 1;5(11):1274-1280
pubmed: 32845276
Life Sci. 2020 Jul 15;253:117723
pubmed: 32360126
J Accid Emerg Med. 1994 Sep;11(3):149-53
pubmed: 7804577
Ann Emerg Med. 1992 May;21(5):541-4
pubmed: 1570910
J Med Virol. 2021 Jan;93(1):51-55
pubmed: 32484975

Auteurs

Hugo De Carvalho (H)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Lucas Leonard-Pons (L)

Department of Emergency Medicine, SAMU85, CHD La Roche Sur Yon, 85000, La Roche Sur Yon, France.

Julien Segard (J)

Department of Emergency Medicine, SAMU44, 44600, Saint Nazaire, France.

Nicolas Goffinet (N)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

François Javaudin (F)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Arnaud Martinage (A)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Guillaume Cattin (G)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Severin Tiberghien (S)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Dylan Therasse (D)

Cardiology, Centre Laroiseau, 56000, Vannes, France.

Marc Trotignon (M)

Department of Emergency Medicine, SAMU85, CHD La Roche Sur Yon, 85000, La Roche Sur Yon, France.

Fabien Arabucki (F)

Department of Cardiology, CHD La Roche Sur Yon, 85000, La Roche Sur Yon, France.

Simon Ribes (S)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Quentin Le Bastard (Q)

Department of Emergency Medicine SAMU44, 44000, Nantes, France.

Emmanuel Montassier (E)

Department of Emergency Medicine SAMU44, 44000, Nantes, France. emmanuel.montassier@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH